Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis (Q28293370)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 15, 2010

Language	Label	Description	Also known as
English	Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis	scientific article published on September 15, 2010

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis (English)

0 references

1 reference

based on heuristic

inferred from title

B. C. J. M. Fauser

7

object named as

B C J M Fauser

0 references

Monique Sterrenburg

1

object named as

M. D. Sterrenburg

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

author name string

S. M. Veltman-Verhulst

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

M. J C. Eijkemans

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

E. G. Hughes

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

N. S. Macklon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

F. J. Broekmans

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

language of work or name

0 references

publication date

2011

1 reference

15 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20843965

13 July 2024

Human Reproduction Update

0 references

17

0 references

2

0 references

184-96

0 references

Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Management of infertility

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Manipulation of human ovarian function: physiological concepts and clinical consequences

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Gonadotropin-releasing-hormone-receptor antagonists

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A population model for the follicular growth in women treated with follicle stimulating hormone

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

The science behind 25 years of ovarian stimulation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Cumulative live-birth rates after in vitro fertilization.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

The ISMAAR proposal on terminology for ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Advanced methods in meta-analysis: multivariate approach and meta-regression.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI.

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMQ041

21 January 2018

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

11

1 reference

10.1093/HUMUPD/DMQ041

https://api.crossref.org/works/10.1093/HUMUPD/DMQ041

13 July 2024

A group-comparative, randomized, double-blind comparison of the efficacy and efficiency of two fixed daily dose regimens (100- and 200-IU) of recombinant follicle stimulating hormone (rFSH, Puregon) in Asian women undergoing ovarian stimulation for

12

1 reference

10.1093/HUMUPD/DMQ041

https://api.crossref.org/works/10.1093/HUMUPD/DMQ041

13 July 2024

Journal of the Medical Association of Thailand = Chotmaihet thangphaet

26

87

1151

author name string

Pruksananonda

publication date

2004

1 reference

10.1093/HUMUPD/DMQ041

https://api.crossref.org/works/10.1093/HUMUPD/DMQ041

13 July 2024

Identifiers

10.1093/HUMUPD/DMQ041

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28293370&oldid=2203538424"